Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
US-12559562-B2 · Feb 24, 2026 · US
This page is not indexed by search engines while we improve data quality.
Scholler John patents
Scholler John is listed as an inventor on 48 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Scholler John |
| Total patents | 48 |
| First publication | Jan 15, 2015 |
| Latest publication | Feb 24, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer
US-2025295774-A1 · Sep 25, 2025 · US
Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
US-12350334-B2 · Jul 8, 2025 · US
Chimeric antigen receptor therapy in combination with il-15r and il15
US-2025215096-A1 · Jul 3, 2025 · US
Use of the CD2 signaling domain in second-generation chimeric antigen receptors
US-12234274-B2 · Feb 25, 2025 · US
Use of icos-based cars to enhance antitumor activity and car persistence
US-2024301024-A1 · Sep 12, 2024 · US
TREATMENT OF CANCER USING HUMANIZED ANTI-EGFRvIII CHIMERIC ANTIGEN RECEPTOR
US-2024238396-A1 · Jul 18, 2024 · US
CCR4-Targeting Chimeric Antigen Receptor Cell Therapy
US-2024122981-A1 · Apr 18, 2024 · US
Use of ICOS-based cars to enhance antitumor activity and car persistence
US-11958892-B2 · Apr 16, 2024 · US
Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor
US-11865167-B2 · Jan 9, 2024 · US
Recent patents
Latest publications not already listed above.
Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer
US-2023416408-A1 · Dec 28, 2023 · US
Compositions and methods for targeting stromal cells for the treatment of cancer
US-11718685-B2 · Aug 8, 2023 · US
Use of the cd2 signaling domain in second-generation chimeric antigen receptors
US-2023242612-A1 · Aug 3, 2023 · US
Use of the CD2 signaling domain in second-generation chimeric antigen receptors
US-11597754-B2 · Mar 7, 2023 · US
Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
US-11299536-B2 · Apr 12, 2022 · US
Compositions and Methods for Generating a Persisting Population of T Cells Useful for the Treatment of Cancer
US-2022056116-A1 · Feb 24, 2022 · US
Use of the cd2 signaling domain in second-generation chimeric antigen receptors
US-2021371495-A1 · Dec 2, 2021 · US
Treatment of cancer using humanized anti-cd19 chimeric antigen receptor
US-2021284752-A1 · Sep 16, 2021 · US
Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells
US-11028177-B2 · Jun 8, 2021 · US
Treatment of cancer using humanized anti-CD19 chimeric antigen receptor
US-10927184-B2 · Feb 23, 2021 · US
Combination therapy using a chimeric antigen receptor
US-2021038659-A1 · Feb 11, 2021 · US
Use of icos-based cars to enhance antitumor activity and car persistence
US-2021009652-A1 · Jan 14, 2021 · US
Chimeric antigen receptor therapy in combination with il-15r and il15
US-2020399383-A1 · Dec 24, 2020 · US
Compositions and methods for generating a persisting population of T cells useful for the treatment of cancer
US-10800840-B2 · Oct 13, 2020 · US
Compositions and Methods for Targeting Stromal Cells for the Treatment of Cancer
US-2020079874-A1 · Mar 12, 2020 · US
Use of ICOS-based CARS to enhance antitumor activity and CAR persistence
US-10577407-B2 · Mar 3, 2020 · US
Use of the CD2 signaling domain in second-generation chimeric antigen receptors
US-10501519-B2 · Dec 10, 2019 · US
Use of the cd2 signaling domain in second-generation chimeric antigen receptors
US-2019352369-A1 · Nov 21, 2019 · US
Treatment of cancer using humanized anti-egfrviii chimeric antigen receptor
US-2019330356-A1 · Oct 31, 2019 · US
Compositions and methods for targeting stromal cells for the treatment of cancer
US-10329355-B2 · Jun 25, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Pennsylvania | 48 |
| Novartis Ag | 17 |
| Wistar Inst | 6 |
| June Carl H | 3 |
| Scholler John | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K14/7051 | 47 |
| A61K40/11 | 41 |
| A61K40/31 | 41 |
| A61P35/00 | 37 |
| C07K16/30 | 32 |